Article
Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
Human molecular genetics - 1 Jul 2004
Ninio Ewa, Tregouet David, Carrier Jean-Luc, Stengel Dominique, Bickel Christoph, Perret Claire, Rupprecht Hans J, Cambien François, Blankenberg Stefan, Tiret Laurence
Abstract excerpt
Oxidation of low density lipoproteins is an initial step of atherogenesis that generates pro-inflammatory phospholipids, including platelet-activating factor (PAF) and its analogs. PAF is degraded by PAF-acetylhydrolase (PAF-AH), a circulating enzyme having both pro- and anti-inflammatory activities. PAF-AH activity has been postulated to be a risk factor for coronary artery disease (CAD); however, whether PAF-AH...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
